19 October 2026
Macfarlane Group PLC
(“Macfarlane” or the “Group”)
Transaction in Own Shares
and
Total Voting Rights
Further to its announcement on 1 October 2026 of the commencement of a share buyback programme (the “Programme”), Macfarlane announces that it has purchased for cancellation, through Shore Capital Stockbrokers Limited, the following ordinary shares of 25 pence each in the Company (“Ordinary Shares”).
|
Date of purchase: |
Number of Ordinary Shares purchased (aggregated volume): |
Highest price paid per Ordinary Share (pence): |
Lowest price paid per Ordinary Share (pence): |
Volume weighted average price paid per share Ordinary Share (pence): |
|
12/10/2026 |
45,228 |
85.000 |
84.880 |
84.9540 |
|
13/10/2026 |
46,184 |
84.000 |
83.500 |
83.6130 |
|
14/10/2026 |
46,981 |
83.100 |
82.730 |
82.9560 |
|
15/10/2026 |
46,363 |
81.950 |
81.950 |
81.9500 |
|
16/10/2026 |
50,000 |
82.100 |
81.650 |
81.7850 |
Following the cancellation of the Ordinary Shares, the Company’s issued share capital will consist of 154,024,748 Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. The total number of voting rights in the Company is therefore 154,024,748. This figure represents the total voting rights in the Company may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure Guidance and Transparency Rules of the FCA.
In accordance with Article 5(1)(b) of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, a detailed breakdown of individual trades is available below:
|
Date of purchase: |
Number of Ordinary Shares purchased |
Transaction price |
Time of transaction |
Venue |
|
12/10/2026 |
13,000 |
85.000 |
11.41 |
XLON |
|
12/10/2026 |
17,500 |
84.880 |
14.20 |
XLON |
|
12/10/2026 |
14,728 |
85.000 |
15.48 |
XLON |
|
13/10/2026 |
13,184 |
83.500 |
15.20 |
XLON |
|
13/10/2026 |
23,000 |
83.510 |
15.10 |
XLON |
|
13/10/2026 |
10,000 |
84.000 |
13.14 |
XLON |
|
14/10/2026 |
15,000 |
83.100 |
10:11 |
XLON |
|
14/10/2026 |
10,000 |
82.730 |
13:06 |
XLON |
|
14/10/2026 |
21,981 |
82.960 |
16:08 |
XLON |
|
15/10/2026 |
46,363 |
81.950 |
13:55 |
XLON |
|
16/10/2026 |
15,000 |
82.100 |
13:49 |
XLON |
|
16/10/2026 |
35,000 |
81.650 |
14:33 |
XLON |
Further enquiries: |
Macfarlane Group |
Tel: 0141 333 9666 |
|
Peter Atkinson Chief Executive |
||
|
Ivor Gray Finance Director |
||
|
James Macdonald Company Secretary |
||
|
|
Spreng Thomson |
|
|
Callum Spreng |
Mob: 07803 970103 |
Notes to Editors
- Macfarlane Group PLC has been listed on the Main Market of the London Stock Exchange (LSE: MACF) since 1973 with over 75 years’ experience in the UK packaging industry.
-
Through its two divisions, Macfarlane Group services a broad range of business customers, supplying them with high quality protective packaging products which help customers reduce supply chain costs, improve operational efficiencies and sustainability and enhance their brand presentation. The divisions are:
- Packaging Distribution – Macfarlane Packaging Distribution is the leading UK distributor of a comprehensive range of protective packaging products; and
- Manufacturing Operations - Macfarlane Design and Manufacture is a UK market leader in the design and production of protective packaging for high value and fragile products.
- Headquartered in Glasgow, Scotland, Macfarlane Group employs over 1,200 people at 42 sites, principally in the UK, as well as in Ireland, Germany and the Netherlands.
- Macfarlane Group supplies more than 20,000 customers, principally in the UK and Europe.
- In partnership with over 2,000 suppliers, Macfarlane Group distributes and manufactures products for a wide range of sectors, including: logistics; electronics; defence; medical; automotive; aerospace; retail e-commerce; and food.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.